PGP and neoplasm: Compared to non-specific nano-carriers or free drugs, drugs loaded in nanoparticles modified with tumor-targeting ligands can enter the target cells through different mechanisms to avoid the drug transporter P-gp, MRP and MCRP and to increase the intracellular accumulation of drugs, so that to reverse MDR.